Startups

Raven StealthCo - Associate Scientist, In Vitro Pharmacology and Assay Development

Raven · Boston, MA · On-site

← All jobs
About Raven

Secure apps with our Runtime Protection Platform. De-prioritize 99% of vulnerabilities with runtime reachability and prevent exploits, zero-days and supply chain attacks with intelligent, library-level policies. Backed by Norwest.

About the role

The two are connected by deep molecular biology, biochemistry, and -omics fluency, and as programs move toward development, translational biomarker work grows more central. As a founding member of the scientific team, this person helps build the lab and define how our core assays run. First-year priorities are clear: stand up cell culture, bring the CRO-run cell-based screening in-house, and establish the tissue-processing and ex vivo readouts our programs depend on.

What they're looking for

  • BS with 8+ years or MS with 6+ years of relevant experience, preferably in biotech settings. Title will be commensurate with depth of qualifications and experience
  • Strong molecular biology and biochemistry: RNA and protein isolation from cells and tissues and quantitative gene- and protein-expression analysis (RT-qPCR, ddPCR, MSD/ELISA, Protein Simple, flow cytometry)
  • Fluency accessing and synthesizing -omics datasets (RNA-seq, spatial transcriptomics, metabolomics, proteomics), with enough grounding in the methods to scrutinize and interpret the data
  • A track record of establishing a method, assay, or capability that did not previously exist in a lab, including the documentation and training that made it reliable for others
  • Initiative and independent scientific thinking: identifying a problem, proposing an approach, and carrying it through with limited supervision
  • Process- and detail-oriented, with the creativity to build novel assays while keeping data decision-grade, and an effective communicator who operates independently in the lab
More about this role

We are Raven, RA Capital’s healthcare incubator. From discovery to delivery, whether we incubate, accelerate or rejuvenate, Raven’s goal is to turn scientific breakthroughs into transformative therapies and get them quickly, safely and efficiently to the patients that need them most. Raven’s experienced scientists, operators, and healthcare innovators have deep sector expertise across therapeutics, diagnostics, devices and services. They have brought hundreds of therapeutics into development, managed hospital systems, optimized clinical trials and navigated payor and regulatory systems to deliver patient impact - and they are ready to work with you.

Founded in 2004, RA Capital Management is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare, life sciences, and planetary health companies. RA Capital creates and funds innovative companies, from private seed rounds to public follow-on financings, allowing management teams to drive value creation from inception through commercialization and beyond. RA Capital's knowledge engine is guided by our TechAtlas internal research division, and Raven, RA Capital’s company building team,...

Read the full posting on Raven's site ↗

Raven

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.